
|Articles|September 1, 2005
Follow-up care for survivors of breast and prostate cancer
Breast cancer has been diagnosed and treated in approximately 2 million women living in the United States, and the incidence of prostate cancer—now second in prevalence to lung cancer in men—has shown a slow but steady increase.1 Cancers of the breast and prostate are hormone-dependent, and this has been the focus of intense research that has resulted in the new, effective adjuvant therapies that are in use today.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
4


























































































































































